期刊文献+

乙醛脱氢酶1在结肠癌组织中的表达及其临床意义 被引量:10

Expression of aldehyde dehydrogenase 1 in colon cancer and its clinical significance
原文传递
导出
摘要 目的探讨乙醛脱氢酶1(Aldehyde Dehydrogenase 1,ALDH1)在结肠癌组织中的表达及其临床意义。方法应用免疫组化SP法检测98例结肠癌组织和15例癌旁组织中ALDH1蛋白的表达情况,分析ALDH1蛋白的表达与临床病理因素的关系及对结肠癌预后的影响。结果 ALDH1蛋白在结肠癌组织中的表达率为76.5%(75/98),癌旁组织中表达率为13.3%(2/15),两者具有统计学差异(P<0.05)。ALDH1表达与结肠癌的组织分化程度、临床分期、淋巴结转移密切有关,该3因素的分组间差异有统计学意义(P<0.05)。ALDH1阴性组结肠癌患者的预后明显好于阳性组患者。结论 ALDH1在结肠癌发生、发展中具有重要作用,可能成为结肠癌诊断的新的生物标志物和判断其生物学行为、预测转移趋势及预后的有价值指标。[中国普通外科杂志,2011,20(3):269-272] Objective To study the expression of ALDH1 in colon cancer and its clinical significance. Methods The expression of ALDH1 was examined in 98 surgical specimens of primary colonic carcinoma and 15 adjacent cancer tissues with immunohistochemistry method.The correlations of the ALDH1 expression with clinicopathological parameters and prognosis of colon cancer were analyzed. Results The positive rate of expression of ALDH1 was 76.5%(75/98) in cancer tissues and 13.3%(2/15) in adjacent cancer tissues.There was an obvious statistical difference(P0.05) between the two groups.The ALDH1 expression was significantly correlated with the histological grade,TNM stages and lymph node metastasis of colon cancer(P0.05).It was also related with patients′survival time,and those with positive expressions had a poor prognosis(P0.05). Conclusions The results suggest that the overexpression of ALDH1 plays important role in development and progression of colon cancer,and ALDH1 may be a valuable marker to predict the biological behavior and trend of metastasis of colon cancer.
出处 《中国普通外科杂志》 CAS CSCD 北大核心 2011年第3期269-272,共4页 China Journal of General Surgery
关键词 结肠肿瘤/病理学 乙醛脱氢酶1 Colonic Neoplasms/pathol Aldehyde Dehydrogenase 1
  • 相关文献

参考文献12

  • 1Giuliani F, De Vita F, Colucci G, et al. Maintenance therapy in colon cancer [J]. Cancer Treat Rev, 2010, 36 (3) :s42 -s45.
  • 2Yoshida A, Hsu LC, Dave' V. Retinal oxidation activity and biological role of human cytosolic aldehyde dehydrogenase [J]. Enzyme, 1992, 46 (4 -5) :239 -244.
  • 3Huang EH, Hynes MJ, Zhang T, et al. Aldehyde dehydro- genase 1 is a marker for normal and malignant human colonic stem cells ( SC ) and tracks SC overpopulation during colon tumorigenesis [J]. Cancer Res,2009, 69(8) :3382 - 3389.
  • 4Luo J, Zha S, Gage WR, et al. Alpha-methylacyl-CoA racemase : a new molecular marker for prostate cancer [ J ]. Cancer Res, 2002, 62 ( 8 ) :2220 - 2226.
  • 5Hess DA, Craft TP, Wirthlin L, et al. Widespread non- hematopoietic tissue distribution by transplanted human progenitor cells with high aldehyde dehydrogenase activity [ J ]. Stem Ceils, 2006, 26(8) :611 -620.
  • 6Chute JP, Muramoto GG, Whitesides J, et al. Inhibition of aldehyde dehydrogenase and retinoid signaling induces the expansion of human hematopoietic stem cells [ J ]. Proc Natl Acad Sci USA,2006, 103 (31) :11707 - 11712.
  • 7Fallon P, Gentry T, Bailer AE, et al. Mobilized peripheral blood SSC loALDHbr cells have the phenotypic and functional properties of primitive haematopoietic cells and their number correlates with engraftment following autologous transplantation [J]. Sr J naematol, 2003, 122 (1): 99-108.
  • 8Li T, Su Y, Mei Y, et al. ALDH1A1 is a marker for malignant prostate stem cells and predictor of prostate cancer patients outcome [ J ] . Laboratory Investigation, 2 010, 9 0 (2) : 234 -244.
  • 9Jiang F, Qiu Q, Khanna A, et al. Aldehyde dehydrogenase 1 is a tumor stem cell-associated marker in lung cancer [J]. Mol Cancer Res, 2009, 7(3):330 -338.
  • 10Su Y, Qiu Q, Zhang X, et al. Aldehyde dehydrogenase 1 A1-positive cell population is enriched in tumor-initiating cells and associated with progression of bladder cancer [J]. Cancer Epidemiol Biomarkers Prey, 2010, 19 (2) :327 - 337.

二级参考文献19

  • 1Ginestier C, Hur MH, Charafe-Jauffret E, et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome[J]. Cell Stem Cell, 2007,1(5) :555- 567.
  • 2Balicki D. Moving forward in human mammary stem cell biology and breast cancer prognostication using ALDH1 [J]. Cell Stem Cell, 2007,1 (5) : 485 - 487.
  • 3Lin S,Ginestier C,Charafe-Jauffret E,et al. BRCAI regulates human mammary stem/progenitor cell fate[J]. Proc Natl Acad Sci USA, 2008,105 (5) : 1680 - 1685.
  • 4Charafe-Jauffret E, Ginestier C, Iovino F, et al. Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature[J]. Cancer Res, 2009,69(4) : 1 302 - 1 313.
  • 5Morimoto K,Kim SJ, Tanei T, et al. Stem cell marker aldehyde dehydrogenase 1 positive breast cancers are characterized by negative estrogen receptor, positive human epidermal growth factor receptor type 2, and high Ki67 expression[J]. Cancer Sci, 2009, 100 (6) :1 062-1 068.
  • 6Korkaya H, Paulson A, Iovino F, et al. HER2 regulates the mammary stem/progenitor cell population driving tumorigenesis and invasion[J]. Oncogene,2008,27(47) :6 120 - 6 130.
  • 7Croker AK,Goodale D, Chu J,et al. High aldehyde dehydrogenase and expression of cancer stem cell markers selects for breast cancer cells with enhanced malignant and metastatic ability[J]. J Cell Mol Med, 21109,13 (8B) : 2 236 - 2 252.
  • 8Anders C, Carey LA. Understanding and treating triple-negative breast cancer[J]. Oncology, 2008,22 ( 11 ) : 1 233 - 1 239.
  • 9Cleator S, Heller W, Coombes RC. Triple-negative breast cancer: therapeutic options[J]. Lancet Oncol, 2007,8 (3) :235 - 244.
  • 10Jolicoeur F,Garcia de la Fuente I,Gaboury L,et al. ALDH1 is a useful marker of basal ness in human breast cancer and its stem/progenitor cells [J]. Cancer Res, 2009, 69 ( 2 Suppl) : Abstract nr 104.

共引文献20

同被引文献106

引证文献10

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部